Investissements Purpose dévoile un nouveau FNB de jalonnement Ether après la conversion d’Ether Capital Corporation en FNB
June 17, 2024 07:30 ET
|
Investissements Purpose
TORONTO, 17 juin 2024 (GLOBE NEWSWIRE) -- Investissements Purpose Inc. (« Purpose ») est fière d’annoncer le lancement du FNB Purpose Ether Staking Corp. (le « FNB » ou « FNB EtherHCB »)...
Purpose Investments Unveils New Ether Staking ETF Following Conversion of Ether Capital Corporation into an ETF
June 17, 2024 07:30 ET
|
Purpose Investments Inc.
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. ("Purpose") is proud to announce the launch of the Purpose Ether Staking Corp. ETF (the "ETF" or "ETHC.B"), formerly Ether Capital...
Venus Concept Announces Exclusive Strategic Supply Arrangement with Skin Laundry
June 17, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has entered a...
Sparton Announces Private Placement Offering of up to C$500,000 For its Critical Metals and Gold Exploration Programs
June 17, 2024 07:30 ET
|
Sparton Resources Inc.
Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, June 17, 2024 (GLOBE NEWSWIRE) -- Sparton Resources Inc. (TSXV-SRI) (“Sparton” or the...
Aqua-Tots Swim School Launches Newest Year-Round Location in North Canton, Ohio
June 17, 2024 07:30 ET
|
Aqua-Tots Swim Schools
Akron, Ohio, June 17, 2024 (GLOBE NEWSWIRE) -- Aqua-Tots Swim School is thrilled to share that its’ seventh location in Ohio is now open and welcoming swimmers in the lakeside community of North...
Intellia Therapeutics to Present the First-Ever Clinical Data From Patients Redosed with an Investigational In Vivo CRISPR Gene Editing Therapy at the Peripheral Nerve Society Annual Meeting 2024
June 17, 2024 07:30 ET
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
June 17, 2024 07:30 ET
|
Avalo Therapeutics
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board,...
nCino Deploying Banking Advisor, a Generative AI Solution to Drive New Efficiencies in Financial Institutions
June 17, 2024 07:30 ET
|
nCino, Inc.
Company's Gen AI tool, powered by nCino IQ (nIQ), delivers real-time intelligence and optimizes decision-making with data-driven insights for financial institutions across asset sizes and geographies ...
UNITEDHEALTH GROUP INC. (NYSE: UNH) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against UnitedHealth Group Inc.
June 17, 2024 07:15 ET
|
Bernstein Liebhard LLP
Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against UnitedHealth Group Inc.
ALTIMMUNE, INC. (NASDAQ: ALT) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Altimmune, Inc.
June 17, 2024 07:15 ET
|
Bernstein Liebhard LLP
Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Altimmune, Inc.